fda approval of tirzepatide Day 4: Zepbound (Tirzepatide – weight loss indication) Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management Is Tirzepatide FDA Approved?

With its unique dual-action mechanism, the medication has the potential to transform the lives of individuals with diabetes, enhancing their overall well-being and reducing the risk of complications

Ninety-two percent occurred in female participants

Both require medical screening and ongoing clinician oversight to ensure safety

Start your intake Tirzepatide Half-Life and Elimination Timeline Tirzepatide has a terminal half-life of approximately 5 days, which means the concentration of active medication in your bloodstream decreases by 50% every 5 days after your final injection

As medical professionals committed to patient safety, we believe transparency is the only antidote to misinformation

W., Kawamura, K., Cheng, Y